Let s begin with, why research is important for Cancer Therapy Market? It is always important because it gives direction to deal with a specific problem. Report Ocean has recently published a market research report on the Cancer Therapy Market which will provide you a leading direction of Cancer Therapy Market. This research report keenly focusses on development status and recent trends of the Cancer Therapy Market, along with competitive landscape, supply chain, market dynamics (opportunities, restraints, and drivers), government policies and opportunities.
Under the accord, the two companies will develop and commercialize MO B2, a prediction kit for metastasis, and recurrence of cancer based on the mechanism of action of the BAG2 protein, MedPacto said in a press release.BAG2 is a protein that plays a role in inducing metastatic activity by binding to cathepsin B, which helps the proliferation, recurrence, and metastasis of tumor cells in the microenvironment around cancer tissue. MedPacto has become the world #39;s first to identify the mechanism of how BAG2 protein is secreted out of cells in TNBC.
The health threat posed by the coronavirus pandemic is particularly intense for people with cancer. Medication weakens the immune system. Cancer treatments are often delayed. FG Trade Getty Images hide caption
The Times of India News App for Latest City News
Aroostook Bangor Central Maine Down East Hancock Midcoast Piscataquis Portland York Maine Life Act Out Homestead Outdoors Business Opinion Obituaries Public Notices Login Logout Subscribe Open Search Search for: Search Menu Don #039;t missHarpswell Shark Attack CMP Corridor Kim Rosen Coronavirus Posted inNational Politics Ruth Bader Ginsburg waited 4 months to say her cancer had returned by The Associated Press 12 hours ago12 hours ago Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Reddit (Opens in new window)Click to print (Opens in new window)Click to email this to a friend (Opens in new window) In this Feb. 10, 2020, file photo U.S. Supreme Court Associate Justice Ruth Bader Ginsburg speaks during a discussion on the 100th anniversary of the ratification of the 19th Amendment at Georgetown University Law Center in Washington. Credit: Patrick Semansky AP WASHINGTON Justice Ruth Bader Ginsburg is perhaps the most forthcoming member of the Supreme Court when it comes to telling the public about her many health issues. But she waited more than four months to reveal that her cancer had returned and that she was undergoing chemotherapy.
Members of Congress and the public paid tribute to the late U.S. Rep. John Lewis (D Ga.) this week at the U.S. Capitol in both a ceremony in the Capitol Rotunda, where his American flag draped coffin was placed, and on the steps outside the East Front of the Capitol, where members of the public also paid their respects to the civil rights legend.Lewis, who was serving his 17th term in Congress, died July 18 at the age of 80 from complications associated with pancreatic cancer.
There are many ways of treating lung cancer. But the procedure that a doctor will ultimately adopt depends on a lot of things like the type of lung cancer and how far it has spread. People with non small cell lung cancer are often treated with surgery, chemotherapy, radiation therapy and targeted therapy. Sometimes, a combination of these treatments may also be used. People with small cell lung cancer are usually treated with radiation therapy and chemotherapy. Today, on the occasion of World Lung Cancer Day, it is important to raise awareness about the various treatments options that are available to people today. It is an ongoing effort of scientists to develop better treatment procedures that will lead to better outcomes. Also Read World Lung Cancer Day 2020: Types and symptoms of lung cancerBut it is important to know that early detection and timely treatment is essential. According to Dr Surender Kumar Dabas, Senior Director amp; HOD, Surgical Oncology amp; Robotic Surgery, BLK Super Specialty Hospital, Due to the COVID 19 scare, patients with lung cancer symptoms are avoiding visiting the hospitals. This comes in the way of an early diagnosis. At the same time, those recently diagnosed are postponing their treatment commencement and those already on treatment are either skipping their chemotherapy or delaying their surgery. He goes on to add that the situation is further compounded by the overlap of symptoms of lung cancer vis a vis COVID 19. This, in turn, means that an early stage curable cancer will eventually advance to a later stage incurable one due to lack of timely treatment intervention. Also Read World Lung Cancer Day 2020: Can diabetes increase your risk of this condition?
Cancer typesCancers in general
Nushafreen was first diagnosed with Non Hodgkin Lymphoma in April 2019. After a year of enduring aggressive treatment, she tried to get back to her normal life and work. Unfortunately, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), cancer relapsed in her liver in May 2020 which was an unexpected major shock, leaving her and all of her family overwhelmed.
Women receiving treatment for ovarian, uterine, and cervical cancers in New York City are not at increased risk of hospitalization or death during COVID 19, according to a study. The study showed that 54% of the women required hospitalization and among these, 25% died, for an overall death rate of 14%. The researchers noted these data are comparable to the results of another study, which showed a 21% death rate among all 5,700 hospitalized patients with COVID 19 in the city, who were mostly male (60%) and at greater risk of the disease, researchers say. Moreover, the results further showed having late stage gynecologic cancer, cancer surgery, or high dose chemotherapy also did not increase a woman s risk of dying from COVID 19.According to a study, the rate of overscreening for certain cancers is high, notably for women living in metropolitan areas. Women living in metropolitan areas were more likely to be overscreened for colorectal cancer, cervical cancer, and breast cancer. Overscreening was more common among women with a usual source of care, compared to those who did not have one, for cervical cancer and breast cancer. Women with good, very good, or excellent self reported health, compared to those with fair or poor self reported health, also had higher rates of overscreening for cervical cancer and breast cancer. Other factors associated with overscreening for cervical and breast cancers were an educational attainment greater than a high school diploma, compared to a high school diploma or less, and being married or living as married, compared to other marital status.
It is a fact that has long baffled doctors: Cancer in the small intestine is quite rare, whereas colorectal cancer, in a neighboring though much smaller organ, is one of the leading causes of cancer death for men and women. What is it about the colon that seems to ”attract ” cancer?
According to reports, antioxidant rich foods such as black tea, cocoa, or blueberries may increase risk of certain cancers, including colorectal cancer, new Hebrew University study has found. Professor Yinon Ben Neriah at Hebrew University of Jerusalem (HU)''s Lautenberg Center for Immunology and Cancer Research and his team found that cancer mutations are not necessarily always bad. In certain micro environments like the gut, these mutations can actually help the body fight cancer, not spread it. However, if and when the gut microbiome produces high levels of metabolites, like those found in antioxidant rich foods, it can act as a favourable environment to mutates genes and can advance the growth of bowel cancers.
Researchers recently assessed what information and support adolescents and young adults coming off of active cancer treatment need. They interviewed healthcare professionals experienced in providing care for this patient population as well as adolescents and young adults themselves. Both cohorts participated in semistructured phone interviews, and some healthcare professionals also filled out an online survey. Adolescents and young adults aged between 16 and 29 years were recruited from four sites.A total of 12 interviews were conducted with healthcare professionals including nurses (n 8), youth support coordinators (n 2), a medical doctor, and a psychologist; 49 healthcare professionals filled out an online survey. About two thirds of survey participants were nurses (n 30; 61%) working in a specialist adolescent and young adult cancer service or in the specialist service as well as other adult cancer services (n 40; 82%). The majority of those who responded of the survey had more than three years of experience (n 39; 80%).
A team at Nottingham Trent University and University Hospitals Leicester NHS Trust is involved in the work, which they say could reduce invasive biopsies by about 70% and help identify patients needing urgent treatment or closer monitoring.The test is also more accurate than current methods in detecting prostate cancer and is able to confirm the stage of the disease with 99% accuracy.
Wilms tumor remains the most common type of renal tumor in children, according to a large, international study. Meanwhile, the proportion of renal carcinomas among kids increased with age, and so did their incidence over time which the authors think may have something to do with environmental factors. In their study, researchers looked at more than 16,000 cases of malignant renal tumors collected across data from more than 308 population based cancer registries on 5 continents. The total included 15,320 renal tumors in children aged 0 to 14 years and 800 renal tumors in teens aged 15 to 19 years. The study looked into the incidence of renal tumors in 15 world regions and across 5 ethnic groups in the US. The researchers also investigated time trends in incidence from 1996 to 2010 and trends during 4 decades (between the 1970s and the 2000s). The age standardized incidence rate (ASR) of renal tumors among children aged 0 to 14 years was 8.3 per million (95% CI, 8.1 8.4) and 1.4 per million (95% CI, 1.3 1.5) among adolescents aged 15 to 19. The highest ASRs in children were identified in North America and Europe, ranging between 9.1 (95% CI, 8.4 9.7) and 9.8 per million (95% CI, 9.4 10.2). In the US, the highest ASR was found for Black individuals, at 10.9 per million (95% CI, 10.2 11.6). Wilms tumor was found to be the most common type of renal tumor in children aged 0 to 14 years, both in all the different world regions and in ethnic groups in the US. Wilms tumors also constituted more than 90% of all renal tumors in each age group from 1 to 7 years, but the proportion of renal carcinomas also rose with age.Continue ReadingAmong children aged 0 to 14, the researchers also identified 431 cases of kidney sarcomas (age standardized incidence rate ASR , 0.2 per million, 95% CI, 0.2 0.3), and 327 cases of rhabdoid renal tumor (ASR, 0.2 per million, 95% CI, 0.2 0.2), which constituted 3% and 2% of all renal tumors. For both major age groups examined in the study children and adolescents the incidence of renal carcinomas was highest in the Black population in the US. Moreover, the vast majority of 39 medullary carcinoma cases in the US, at 85%, were identified in the Black population.